News

 

Iconovo AB has completed a directed share issue of SEK 75 million

The Board of Directors of Iconovo AB (publ) (”Iconovo” or the ”Company”) has, pursuant to the authorisation granted by the Annual General…

Vilka covid-19-vacciner kommer vi ha i framtiden?

ICOone kan ge flera fördelar Iconovo är med och utvecklar ett inhalerat (pulver) Covid-19 vaccin i vår engångs-inhalator ICOone.…

TV4 om inhalerat covid-19 pulvervaccin från ISR i Iconovos inhalator

Krävs varken vårdpersonal eller svårhanterad kylkedja Det Stockholmsbaserade bolaget ISR har utvecklat ett covidvaccin i pulverform…

See video presentations from Iconovo Capital Markets Day 2021

On May 26th Iconovo held a Capital Markets Day for investors and other stakeholders to Iconovo. If you missed the presentations, you can still…

Iconovo’s high aiming business goals

Biostock published May 25th an article about Iconovo that can be found in its entirety below Last week, Iconovo announced its financial targets for…

Respiratorius and Iconovo collaborate on inhalation product for COPD

Biostock published May 21th an article about Iconovo that can be found in its entirety below The two Lund-based development companies Respiratorius…

Iconovo sets ambitious financial targets for 2026

Iconovo AB (publ), which develops complete inhalation products for a global market, today announces its five-year goals for the business. By…

Iconovo and Respiratorius sign agreement for development of inhalation product to treat COPD

Iconovo AB (publ), which develops complete inhalation products for a global market, and Respiratorius AB (publ), which develops drug candidates…

Iconovo’s CEO on the extended agreement with Amneal

Biostock published May 17th an article about Iconovo that can be found in its entirety below Last week, Iconovo announced that the US and China have…

Iconovo extends agreement with Amneal for generic Symbicort to cover key markets U.S. and China, as well as Nordic sales rights

Iconovo AB (publ), which develops complete inhalation products for a global market, today announced that its collaboration with the U.S. pharmaceutical…